Inclusion Criteria:  Clinical diagnosis of non-infectious uveitis nflammation was controlled for 6 months after drug remission was achieved using Adalimumab in combination with immunosuppressant therapy Family members and patients who are willing to stop should agree and accept relevant examinations The informed consent is read and signed by the patient or a legally authorized represent  Exclusion Criteria:  Unwilling to sign informed consent There is systemic autoimmune disease uncontrolled situation Patients who may require surgery in the near future Vision meets the standards of low vision and blindness Silicone oil or gas filling after vitreous surgery